|
STT3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.378170E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.499900E-02 |
| Normal-vs-Stage2 |
7.845600E-01 |
| Normal-vs-Stage3 |
7.665000E-01 |
| Normal-vs-Stage4 |
9.699200E-01 |
| Stage1-vs-Stage2 |
3.723800E-01 |
| Stage1-vs-Stage3 |
2.265400E-01 |
| Stage1-vs-Stage4 |
4.070200E-01 |
| Stage2-vs-Stage3 |
6.892400E-01 |
| Stage2-vs-Stage4 |
8.912800E-01 |
| Stage3-vs-Stage4 |
8.409600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.392550E-01 |
| Normal-vs-AfricanAmerican |
3.918000E-01 |
| Normal-vs-Asian |
2.400600E-01 |
| Caucasian-vs-AfricanAmerican |
8.158200E-01 |
| Caucasian-vs-Asian |
8.210000E-01 |
| AfricanAmerican-vs-Asian |
7.440000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.570000E-04 |
| Normal-vs-Female |
5.681700E-03 |
| Male-vs-Female |
2.9504999998764E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.282400E-01 |
| Normal-vs-Extreme_Weight |
1.183820E-03 |
| Normal-vs-Obese |
5.674400E-01 |
| Normal-vs-Extreme_Obese |
2.332000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.795700E-02 |
| Normal_Weight-vs-Obese |
4.066400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.199560E-01 |
| Extreme_Weight-vs-Obese |
4.016900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.601200E-01 |
| Obese-vs-Extreme_Obese |
5.549900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.286160E-01 |
| Normal-vs-Age(41-60Yrs) |
9.732000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.018480E-03 |
| Normal-vs-Age(81-100Yrs) |
5.519400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.297010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.816300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.918470E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.763600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.473800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.752600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.038200E-03 |
| Normal-VS-Type2 PRCC |
1.251200E-01 |
| Normal-VS-KIRP CIMP |
2.916100E-02 |
| Normal-VS-Unclassified PRCC |
4.834200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.625000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.106270E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.115600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.632340E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.978300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.045990E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.135410E-01 |
| Normal-vs-N1 |
3.293400E-01 |
| Normal-vs-N2 |
3.299800E-01 |
| N0-vs-N1 |
1.031030E-01 |
| N0-vs-N2 |
2.938600E-01 |
| N1-vs-N2 |
9.399200E-01 |
|
|
